Crescendo Biologics appoints Dr Peter Pack as chief exec
October 15, 2015Business Services, Research and Development
Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …
Novartis and Biogen launch drug access programmes in developing countries
October 15, 2015Manufacturing and Production, Sales and Marketing Biogen, Novartis, access, aid, corporate social responsibility, csr, humanitarian aid
Novartis and Biogen have begun new campaigns aimed at increasing access to medicines in developing countries. The Swiss firm has …
Merck and Incyte to initiate Keytruda, epacadostat combo trial
October 15, 2015Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer
Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …
Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters
October 14, 2015Drug pricing, Hilary Clinton, US, pricing reform
Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …
Turing faces antitrust probe over Daraprim price hike
October 14, 2015Sales and Marketing Daraprim, Turing Pharmaceuticals, turing
Turing Pharmaceuticals, the drug company that increased the price of the generic drug Daraprim 50-fold overnight, is facing an antitrust …
Johnson & Johnson begins Ebola vaccine trial in Sierra Leone
October 14, 2015Research and Development Ebola vaccine, Johnson & Johnson
Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …
AstraZeneca accused of tax avoidance in Dutch scheme
October 14, 2015AstraZeneca, finance, tax, tax avoidance
AstraZeneca is the latest international firm to be accused of corporation tax avoidance, after an investigation claimed the firm is …
Novo chief executive ranked ‘world’s best’
October 14, 2015Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk
Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …
Mayor of London announces Takeda, UCL R&D partnership
October 14, 2015Research and Development London, R&D, Takeda, UCL, neurology
Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …
Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team
October 14, 2015Medical Communications, Research and Development
Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …
Merck rebrands as ‘science and technology’ company
October 14, 2015Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure
Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
Teva joins Watson Health in R&D link-up
October 14, 2015Research and Development Big Data, R&D, Teva, Watson Health, ibm
Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …
Featured Market Report: Gene Therapies Outlook
October 13, 2015Manufacturing and Production, Research and Development
This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …
Shire’s Cinryze gets FDA fast track designation
October 13, 2015Research and Development AMR, FDA, Shire
Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …
AstraZeneca’s MedImmune joins Human Vaccines Project
October 13, 2015Research and Development Human Vaccines Project, MedImmune
MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …
Novartis invests further $15m into Gamida Cell
October 13, 2015Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions
Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
Stefan Oschmann promoted to top job at Merck KGaA
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann
Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
NICE launches new service to speed NHS adoption of health technologies
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access
NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …
Contact manufacturing ‘is changing the industry’, report finds
October 13, 2015Manufacturing and Production CMO, contract manufacturing, manufacturing, pharma, production
The global market for pharma and biopharma contract manufacturing is expected to reach more than €332.7 billion by 2018, according …
Berg interview: artificial intelligence and big data join the war on disease
October 13, 2015Medical Communications, Research and Development AI, Berg, Big Data, genomics
Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
